In addition, preclinical data suggest that the DNA homologous recombination gene BRCA1 may be a positive regulator of MSH2 in HR+/HER2+ breast cancer, suggesting that its tumor-suppressor function can be mediated by the MMR system [50]. This evidence concerns the gene ERBB2 and neoplasm.